Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
ATAI Life Sciences N.V.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| JOHNSON SABRINA MARTUCCI (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $1.88, valued at
$120.3k
|
|
| 05/25/2023 |
4
| Auerbach Michael (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $1.88, valued at
$120.3k
|
|
| 05/25/2023 |
4
| Smiley Andrea Heslin (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $1.88, valued at
$120.3k
|
|
| 05/25/2023 |
4
| Camm Jason (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $1.88, valued at
$120.3k
|
|
| 05/25/2023 |
4
| Angermayer Christian (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $1.88, valued at
$120.3k
|
|
| 05/25/2023 |
4
| Kalali Amir H (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $1.88, valued at
$120.3k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| Rao Srinivas (See Remarks) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 600,000 options
@ $1.18, valued at
$708k
Granted 350,000 restricted stock units
@ $0 |
|
| 03/16/2023 |
4
| Brand Florian (See Remarks) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 1,600,000 options
@ $1.18, valued at
$1.9M
Granted 700,000 restricted stock units
@ $0 |
|
| 03/16/2023 |
4
| Bardin Stephen (CFO) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 600,000 options
@ $1.18, valued at
$708k
Granted 350,000 restricted stock units
@ $0 |
|
| 03/16/2023 |
4
| Gutierrez-Esteinou Rolando (Chief Medical Officer) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 500,000 options
@ $1.18, valued at
$590k
Granted 200,000 restricted stock units
@ $0 |
|
| 03/16/2023 |
4
| Kirpekar Sahil (Chief Business Officer) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 275,000 options
@ $1.18, valued at
$324.5k
Granted 200,000 restricted stock units
@ $0 |
|
| 12/02/2022 |
4
| Kirpekar Sahil (Chief Business Officer) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 750,000 options
@ $3.34, valued at
$2.5M
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| de Rosnay Alexis (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 64,000 options
@ $3.84, valued at
$245.8k
|
|
| 05/03/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 67,703 shares
@ $5.0886, valued at
$344.5k
Bought 68,688 shares
@ $4.9505, valued at
$340k
|
|
| 05/02/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 34,700 shares
@ $4.4579, valued at
$154.7k
Bought 21,900 shares
@ $4.4658, valued at
$97.8k
|
|
| 04/26/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 52,820 shares
@ $4.827, valued at
$255k
Bought 8,961 shares
@ $4.781, valued at
$42.8k
|
|
| 04/20/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 54,322 shares
@ $5.1113, valued at
$277.7k
Bought 65,315 shares
@ $5.125, valued at
$334.7k
|
|
| 04/18/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 4,967 shares
@ $5.19, valued at
$25.8k
|
|
| 04/14/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 55,197 shares
@ $4.8836, valued at
$269.6k
|
|
| 04/12/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 57,689 shares
@ $4.8127, valued at
$277.6k
Bought 53,926 shares
@ $4.8317, valued at
$260.6k
|
|
| 04/07/2022 |
4
| Apeiron Investment Group Ltd. (10% Owner) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 1,000,000 options to buy
@ $10.103, valued at
$10.1M
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| Auerbach Michael (Director) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Disposed of 5,559,808 shares
@ $0 |
|
| 12/28/2021 |
4
| Gutierrez-Esteinou Rolando (Chief Medical Officer) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 325,000 options
@ $7.72, valued at
$2.5M
|
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|